>The revocation of the EUA for Janssen appeared to be unlikely until Johnson & Johnson itself approached the FDA with the request to do so.
you bolded the wrong part.
>The revocation of the EUA for Janssen appeared to be unlikely until Johnson & Johnson itself approached the FDA with the request to do so.
you bolded the wrong part.